Programme d’accompagnement du patient fumeur à l’officine : moi(s) sans tabac, mais avec mon plan d’accompagnement personnalisé à l’officine (PAPO). Expérimentation 2018
Le Pharmacien Hospitalier et Clinicien, ISSN: 2211-1042, Vol: 55, Issue: 2, Page: 178-188
2020
- 3Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
À l’occasion du « moi(s) sans tabac » 2018, nous avons mené le suivi de l’intervention de pharmaciens cliniciens officinaux pour le sevrage de leurs patients fumeurs volontaires. Nous présentons ici le protocole d’accompagnement construit pour fournir aux pharmaciens les consignes et outils nécessaires à l’évaluation de chacune des phases de suivi du patient ( Appendix ; see supplementary material associated with this article on line ). À l’issue de cette expérimentation plus de 40 % des patients ont déclaré avoir arrêté complètement de fumer au bout d’un mois. Ce résultat encourageant permet de poser la question de la possible contribution des pharmaciens d’officine dans le sevrage tabagique. Nous nous inscrivons dans une perspective de déploiement de la pharmacie clinique à l’officine où le pharmacien conjugue expertise technique et communicationnelle. La clé de voûte de l’intervention réside dans un entretien conçu et mené pour offrir un accompagnement et un suivi personnalisé. L’interaction pharmacien–patient, l’alliance qui en découle, sont, pour le patient, le socle de changements, d’abandon de comportements néfastes ou d’adoption de comportements favorables à la santé. Le rôle du pharmacien clinicien d’officine est considéré dans la perspective de valoriser ses compétences et sa disponibilité, au sein d’équipes pluridisciplinaires, dans le cadre d’un accompagnement global du patient. For the 2018 “Tobacco-Free Month”, we assessed intervention of clinical pharmacists to support patients giving up smoking. Here, we present the support protocol providing pharmacists with instructions and tools to assess each phase of patient support ( Appendix; see supplementary material associated with this article on line ). At the end of the program, more than 40% of the patients reported having completely stopped smoking after one month. This encouraging result raises the question of the possible contribution of pharmacists to smoking cessation. Our attitude is that the clinical pharmacist combines technical and communication expertise. The key to the intervention is an interview designed and conducted to offer personalized support and follow-up. Pharmacist–patient interaction and the resulting alliance provide the patient with a basis for change, abandoning harmful behaviours and adopting healthy behaviours. The role of the clinical pharmacist is considered from the perspective of making full use of skills and availability, within multidisciplinary teams, as part of global patient support.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2211104220300096; http://dx.doi.org/10.1016/j.phclin.2019.12.008; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85079869924&origin=inward; https://linkinghub.elsevier.com/retrieve/pii/S2211104220300096; https://api.elsevier.com/content/article/PII:S2211104220300096?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S2211104220300096?httpAccept=text/plain; https://dul.usage.elsevier.com/doi/; https://dx.doi.org/10.1016/j.phclin.2019.12.008
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know